ZEYMER, U., H. BUENO, C. B. GRANGER, J. HOCHMAN, K. HUBER, M. LETTINO, S. PRICE, F. SCHIELE, M. TUBARO, P. VRANCKX, D. ZAHGER a H. THIELE. Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology. EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE. LONDON: SAGE PUBLICATIONS LTD, 2020, roč. 9, č. 2, s. 183-197. ISSN 2048-8726. Dostupné z: https://dx.doi.org/10.1177/2048872619894254.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology
Autoři ZEYMER, U., H. BUENO, C. B. GRANGER, J. HOCHMAN, K. HUBER, M. LETTINO, S. PRICE, F. SCHIELE, M. TUBARO, P. VRANCKX, D. ZAHGER a H. THIELE.
Vydání EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, LONDON, SAGE PUBLICATIONS LTD, 2020, 2048-8726.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30230 Other clinical medicine subjects
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
WWW DAPT-SHOCK AMI
Impakt faktor Impact factor: 4.696
Kód RIV RIV/00216224:14110/20:00123182
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1177/2048872619894254
UT WoS 000517721200001
Klíčová slova česky DAPT-SHOCK AMI; Acute myocardial infarction; Cardiogenic shock; Revascularuzation therapies; mechanical circulatory support
Klíčová slova anglicky DAPT-SHOCK AMI; Acute myocardial infarction; Cardiogenic shock; Revascularuzation therapies; mechanical circulatory support
Štítky Excelence Science, RIV, UK LF PRAHA, user
Příznaky Mezinárodní význam
Změnil Změnila: Bc. Hana Vladíková, BBA, učo 244692. Změněno: 10. 2. 2022 13:50.
Anotace
(Dual Antiplatelet Therapy for Shock patients with Acute Myocardial Infarction (DAPT-SHOCK-AMI) trial; ClinicalTrials.gov: NCT03551964). Most of the guideline-recommended treatment strategies for patients with acute coronary syndromes have been tested in large randomised clinical trials. Still, a major challenge is represented by patients with acute myocardial infarction admitted with impending or established cardiogenic shock. Despite early revascularization the mortality of cardiogenic shock remains high and roughly half of patients do not survive until hospital discharge or 30-day follow-up. However, there is only limited evidence-based scientific knowledge in the cardiogenic shock setting. Therefore, recommendations and actual treatments are often based on retrospective or prospective registry data and extrapolations from randomised clinical trials in acute myocardial infarction patients without cardiogenic shock. This position statement will summarise the current consensus of the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock based on current evidence and will provide advice for clinical practice.
Návaznosti
90128, velká výzkumná infrastrukturaNázev: CZECRIN III
VytisknoutZobrazeno: 20. 7. 2024 21:21